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Summary
Background.  —  Catheter  ablation  is  an  effective  and  potentially  curative  treatment  in  patients
with atrial  ﬁbrillation  (AF).peak  ﬂow  velocity; Aim.  —  To  test  the  hypothesis  that  left  atrial  appendage  peak  ﬂow  velocity  (LAV)  assessed  by
Catheter  ablation;
Echocardiography;
Radiofrequency
echocardiography  can  accurately  predict  successful  catheter  ablation  as  well  as  favourable
outcome in  the  setting  of  long-standing  persistent  AF.
Methods.  —  This  prospective  pilot  study  enrolled  40  patients  with  long-standing  persistent  AF
(age 60  ±  11  years;  persistence  of  AF  4.2  ±  2  years)  who  underwent  a  ﬁrst  catheter  ablation
Abbreviations: AF, atrial ﬁbrillation; CI, conﬁdence interval; ECG, electrocardiogram; IQR, international normalized ratio; LAV, left
trial appendage peak ﬂow velocity; OR, odds ratio; ROC, receiver operating characteristics.
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procedure  using  a  standardized  sequential  stepwise  protocol.  LAV  was  assessed  before  the
catheter ablation  procedure  along  with  classical  factors  (age,  sex,  left  atrial  area,  AF  cycle
length, AF  duration  and  left  ventricular  ejection  fraction),  all  of  which  were  tested  using  logis-
tic regression  for  ability  to  predict  restoration  of  sinus  rhythm  during  catheter  ablation  as  well
as absence  of  recurrence  during  a  1-year  follow-up.
Results.  —  Eighteen  patients  (45%)  experienced  AF  termination  during  the  procedure  and  18
patients (45%)  did  not  develop  any  recurrence  during  the  ﬁrst  12  months.  Multivariable  analysis
demonstrated  that  high  LAV  (>  0.3  m/s)  was  the  only  independent  predictor  of  AF  termination
(odds ratio  5.91,  95%  conﬁdence  interval  1.06—32.88;  P  =  0.04)  and  absence  of  recurrence  at
1 year  (odds  ratio  4.33,  95%  conﬁdence  interval  1.05—17.81;  P  =  0.04).
Conclusions.  —  This  pilot  study  demonstrated  the  feasibility  and  importance  of  LAV  measure-
ment in  the  setting  of  long-standing  persistent  AF  to  predict  successful  catheter  ablation  and
favourable  mid-term  outcome.
© 2012  Published  by  Elsevier  Masson  SAS.
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Résumé  L’ablation  par  cathéter  est  un  traitement  efﬁcace  et  potentiellement  curatif  chez
les patients  atteints  de  ﬁbrillation  auriculaire  (FA).  Nous  avons  supposé  que  le  pic  de  vitesse  de
vidange de  l’auricule  gauche  évalué  par  échocardiographie  transœsophagienne  était  en  mesure
de prédire  avec  précision  le  succès  de  l’ablation  ainsi  que  les  résultats  favorables  à  moyen  terme
dans la  FA  persistante.
Méthodes.  — Cette  étude  pilote  prospective  a  recruté  40  patients  présentant  une  FA  persistante
(âge 60  ±  11  ans,  persistance  de  la  FA  4,2  ±  2  ans)  et  ayant  bénéﬁcié  d’une  première  procédure
d’ablation  par  radiofréquence,  utilisant  un  protocole  standardisé  étape  par  étape.  Le  pic  de
vitesse de  vidange  de  l’auricule  gauche  a  été  évalué  avant  la  procédure  d’ablation  par  cathéter
ainsi que  les  autres  facteurs  prédictifs  classiques  (âge,  sexe,  surface  de  l’oreillette  gauche,
la longueur  du  cycle  AF,  durée  de  la  FA  et  la  fraction  d’éjection  ventriculaire  gauche).  Ces
paramètres  ont  été  testés  en  utilisant  une  régression  logistique  pour  (i)  la  restauration  du
rythme sinusal  pendant  la  procédure  d’ablation  par  cathéter  ainsi  que  (ii)  pour  l’absence  de
récidive au  cours  de  la  première  année  de  suivi.
Résultats.  — Dix-huit  patients  (45  %)  ont  connu  un  arrêt  de  la  FA  pendant  la  procédure  et
18 patients  (45  %)  n’ont  pas  développé  de  récidive  au  cours  des  12  premiers  mois.  L’analyse
multivariée  a  démontré  que  les  vélocités  hautes  dans  l’auricule  (>  0,3  m/s)  étaient  le  seul  fac-
teur prédictif  indépendant  d’arrêt  de  la  FA  per  procédure  (OR  =  5,91,  IC  95  %  :  1,06  à  32,88,
p =  0,04)  et  de  l’absence  de  récidive  à  un  an  (OR  =  4,33,  IC  à  95  %  :  de  1,05  à  17,81,  p  =  0,04).
Conclusions.  —  Cette  étude  pilote  a  démontré  la  faisabilité  et  l’importance  de  la  mesure  de
la vélocité  dans  l’auricule  gauche  avant  l’ablation  de  FA  persistante  pour  prédire  le  succès  de
l’ablation par  cathéter  et  les  résultats  favorables  à  moyen  terme.
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Background
Atrial  ﬁbrillation  (AF)  is  the  most  common  type  of  cardiac
arrhythmia.  If  untreated,  it  leads  to  an  increase  in  cardiovas-
cular  morbidity—particularly  embolic  stroke—and  mortality
[1].  Catheter  ablation  has  been  demonstrated  to  be  a  very
effective  and  potentially  curative  treatment  in  patients
with  paroxysmal  AF  [2—4]. In  contrast,  results  regarding
persistent  AF,  especially  long-standing  persistent  AF,  are
more  controversial,  with  largely  varying  success  rates  [5—7].
Accordingly,  in  the  setting  of  long-standing  persistent  AF,
the  optimization  of  candidate  selection  should  improve  the
success  rate  of  these  procedures  and  therefore  favourably
increase  the  beneﬁt/risk  ratio  of  this  invasive  strategy.
A  number  of  variables  have  been  found  to  have  a  poten-
tial  role  in  predicting  successful  catheter  ablation  and
recurrence  risk:  duration  of  AF;  surface  electrocardiogram
AF  cycle  length;  patient  age;  left  atrial  diameter;  left  ven-
tricular  function;  and,  more  recently,  magnetic  resonance
imaging  delayed  enhancement  of  the  left  atrium  [8—10].
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aken  separately,  however,  the  predictive  value  of  each  of
hese  variables  remains  relatively  low  and  of  limited  interest
n  routine  clinical  practice.
Given  the  pathophysiology  of  AF,  we  hypothesized  that
igh  left  atrial  appendage  peak  ﬂow  velocity  (LAV)  assessed
y  transesophageal  echocardiography  before  catheter
blation  procedure  would  accurately  predict  successful  pro-
edure  and  favourable  outcome.
ethods
tudy population and exclusion criteria
orty  patients  who  had  undergone  ﬁrst-time  radiofrequency
atheter  ablation  for  long-standing  persistent  AF  were
nrolled  from  January  2009  and  followed  until  May  2010
ClinicalTrials.gov  ID:  NCT01144858).  Long-standing  persis-
ent  AF  was  deﬁned  as  AF  that  has  been  present  for  1  year  or
ore,  resistant  to  at  least  one  electrical  or  pharmacological
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ardioversion  and  for  which  a  rhythm  control  strategy  was
ecided.  Exclusion  criteria  included:  age  <  18  or  >  80  years;
evere  valvular  disease  requiring  surgery;  valve  prosthesis;
nown  severe  coronary  artery  disease;  atrial  and/or  ven-
ricular  thrombosis;  New  York  Heart  Association  functional
lass  III—IV;  cerebrovascular  disease;  pulmonary  embolism;
nd  latent  or  manifest  hyperthyroidism.  All  patients  gave
heir  written  informed  consent.
chocardiography study
 complete  echocardiographic  evaluation  was  carried  out
ithin  48  hours  before  the  procedure  using  the  conventional
ransthoracic  approach  and  then  transoesophageal  echocar-
iography  was  carried  out  by  two  different  physicians  in  a
linded  fashion.
First,  conventional  transthoracic  echocardiography  was
erformed  before  and  after  AF  catheter  ablation  (IE33
ystem;  Philips  Medical  Systems,  Andover,  MA,  USA)  with
outine  echocardiographic  measurements,  using  paraster-
al  short  and  long  axes,  and  apical  four-  and  two-chamber
iews.  The  left  atrium  area  was  obtained  via  apical  four-
hamber  zoomed  views  of  the  left  atrium.  Images  and  pulse
oppler  ﬂows  of  mitral  inﬂow  and  tissue  Doppler  imaging
t  the  mitral  annulus  were  acquired  from  the  four-chamber
iews.
Second,  all  patients  were  evaluated  before  catheter
blation  by  complete  transoesophageal  echocardiography
ith  multiplane  probes  using  a  7-MHz  transducer  (Vivid
;  General  Electric  Medical  Health,  Horten,  Norway).  Left
trial  spontaneous  contrast  and  thrombus  were  sought.  After
 complete  analysis  of  the  left  atrial  appendage  at  the  base
f  the  heart  with  rotation  of  the  probe  between  0◦ and  180◦,
he  incidence  with  the  best  alignment  of  the  cursor  with  the
ppendage  long  axis  was  selected.  The  cursor  was  placed
t  the  entry  of  the  appendage  for  pulsed  Doppler  analy-
is  and  we  considered  the  average  value  of  10  consecutive
brillatory  emptying  waves  (Fig.  1)  [11].
utcome measures
he  primary  outcome  was  restoration  of  sinus  rhythm  dur-
ng  the  catheter  ablation  procedure.  The  second  outcome
as  absence  of  recurrence  of  atrial  arrhythmias  (AF,  atrial
achycardia  or  ﬂutter)  during  the  year  following  the  proce-
ure.
lectrophysiological study and catheter
blation procedure
ll  patients  received  effective  anticoagulation  therapy
vitamin  K  antagonists,  target  international  normalized  ratio
IQR]  of  2—3)  for  more  than  1  month  before  ablation.  This
herapy  was  interrupted  at  least  48  hours  before  the  proce-
ure,  with  a  heparin  bridge.  All  antiarrhythmic  drugs  were
iscontinued  1  week  before  the  procedure,  except  for  amio-
arone,  which  was  maintained.
The  electrophysiological  study  was  performed  under
eneral  anaesthesia  using  a  standard  protocol.  The  fol-
owing  catheters  were  introduced  via  the  femoral  vein:  a
teerable  quadripolar  catheter  (Xtrem®;  Sorin  Group,  Le
lessis-Robinson,  France)  was  positioned  within  the  coronary
T
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inus;  a  circumferential  mapping  catheter  (Lasso;  Biosense
ebster,  Diamond  Bar,  CA,  USA)  was  introduced  after
ransseptal  access;  and  a  4-mm  externally  irrigated-tip  abla-
ion  catheter  (Thermocool,  Biosense  Webster)  was  used  for
apping  and  ablation.  After  transseptal  access,  a  single
olus  of  heparin  (100  IU/kg  body  weight)  was  administered.
he  infusion  was  adjusted  to  maintain  an  activated  coag-
lation  time  of  300  s  or  more.  The  transseptal  sheath  was
lso  continuously  infused  with  heparinized  saline  during  the
rocedure.
Surface  electrocardiograms  (ECGs)  and  endocardial  elec-
rograms  were  continuously  monitored  and  recorded  for
ff-line  analysis  (Bard  Electrophysiology,  Lowell,  MA,  USA).
ollowing  transseptal  catheterization,  left  atrial  and  coro-
ary  sinus  electroanatomical  mapping  (Carto  3;  Biosense
ebster)  was  performed  during  spontaneous  AF.  Computed
omography  registration  and  fusion  of  left  atrial  reconstruct-
ons  with  the  electroanatomical  map  were  subsequently
erformed.  Endocardial  AF  cycle  length  was  determined
rom  intracardiac  recordings  at  the  left  atrial  appendage
efore  ablation  and  was  averaged  for  30  consecutive  inter-
als.
In  all  patients,  sequential  stepwise  ablation  described
y  O’Neill  et  al.  [6],  was  performed  by  the  same  opera-
or,  blinded  to  the  echocardiographic  data.  The  procedure
as  terminated  with  the  step  that  allowed  AF  conver-
ion  into  sinus  rhythm  and  no  antiarrhythmic  treatment
as  prescribed  during  the  procedural  period  or  during  the
rocedure.  In  all  cases,  circular  and  linear  lesions  were  ver-
ﬁed  after  sinus  rhythm  restoration.  The  ﬁrst  step  involved
ulmonary  vein  isolation.  The  second  step  included  lin-
ar  ablation  in  the  left  atrium:  a  roof  line  was  drawn
etween  the  right  and  left  superior  pulmonary  veins  and,
f  AF  persisted,  a  mitral  isthmus  line  was  drawn  from  the
itral  annulus  to  the  left  inferior  pulmonary  vein  and  coro-
ary  sinus  defragmentation  was  performed.  The  third  step
onsisted  of  electrogram-based  ablation  of  complex  frac-
ionated  atrial  electrograms  in  the  left  and  right  atria  [5].
omplex  fractionated  atrial  electrogram  sites  were  tagged
n  the  geometry  obtained  from  three-dimensional  mapping
uring  AF.  Lastly,  a  cavotricuspid  isthmus  line  was  performed
nly  in  patients  with  a  history  of  common  atrial  ﬂutter  with
CG  documentation.
When  AF  was  converted  to  a  regular  arrhythmia,
ctivation  and  entrainment  mapping  were  performed  to  dif-
erentiate  between  focal  and  re-entrant  mechanisms.  Atrial
achycardias  were  targeted  for  ablation  until  sinus  rhythm
as  achieved.  When  sinus  rhythm  was  not  restored  by  abla-
ion,  AF  or  atrial  tachycardia  was  terminated  by  electrical
ardioversion  and  the  procedure  was  considered  as  a  failure.
fter  restoration  of  sinus  rhythm,  assessment  of  conduction
lock  across  the  lines  was  performed  in  all  patients  [12].
hen  necessary,  supplemental  radiofrequency  energy  was
elivered  to  achieve  block.
ischarge, follow-up plan and AF recurrence
ssessmentreatment  with  vitamin  K  antagonists  was  resumed  1  day
fter  the  procedure  and  patients  were  discharged  on  day  3
eceiving  low-molecular-weight  heparin  until  they  had  two
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Figure 1. A. Pulsed Doppler tracing of left atrial appendage obtained by transoesophageal echocardiography showing left atrial appendage
peak ﬂow velocity (LAV) at the mouth of the appendage at 80◦ in a patient who achieved successful atrial ﬁbrillation (AF) termination
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consecutive  international  normalized  ratios  >  2.  Patients
were  assessed  before  discharge  and  at  the  third,  sixth
and  12th  months  by  clinical  interview,  echocardiography
and  24-h  Holter  monitoring.  In  addition,  patients  were
instructed  to  call  their  cardiologist  in  case  of  sustained
palpitation,  for  immediate  ECG  recording.  Vitamin  K  antag-
onists  were  prescribed  for  a  minimum  of  3  months  and
potentially  discontinued  in  case  of  low  thromboembolic
score  (CHADS2 score  0  or  1).  Amiodarone  was  continued
for  at  least  3  months  in  patients  who  were  receiving  amio-
darone  before  the  procedure  and  was  interrupted  in  case
of  no  recurrence  at  3  months.  Recurrence  was  deﬁned  as
any  symptomatic  or  asymptomatic  atrial  arrhythmia  last-
ing  >  30  s;  it  was  evidenced  by  Holter  monitoring  at  3,  6
and  12  months  or  by  12-lead  ECG  in  case  of  symptomatic
palpitation  at  clinical  interview.
Statistical analysis
Categorical  variables  are  expressed  as  number  and
proportion,  and  continuous  variables  are  expressed  as
mean  ±  standard  deviation.  Comparison  of  baseline  char-
acteristics  of  patients  with  and  without  AF  termination
by  catheter  ablation  was  performed  using  the  2 test  or
Fisher’s  exact  test  (as  appropriate)  for  categorical  varia-
bles  and  Wilcoxon’s  test  for  continuous  variables.  All  tests
were  two-sided.  A  P  value  <  0.05  was  considered  statistically
signiﬁcant.
LAV  (highly  associated  with  favourable  outcome)  was
studied  by  analysis  of  receiver  operating  characteristics
(ROC)  to  determine  optimal  cutoff  values  for  the  prediction
of  successful  catheter  ablation.  ROC  was  evaluated  using  a
plot  of  the  true  positive  fraction  (sensitivity)  versus  the  true
negative  fraction  (1—speciﬁcity)  with  a  continuously  varying
decision  threshold.  The  best  cutoff  value  was  deﬁned  as  the
point  combining  the  highest  sensitivity  and  speciﬁcity.
Age,  duration  of  AF,  LAV,  left  ventricular  ejection  frac-
tion,  left  atrial  area  and  AF  cycle  length  from  the  left  atrial
appendage  were  considered  in  a  logistic  regression  model  to
identify  criteria  associated  with  successful  catheter  ablation
procedure.  Categorized  variables  with  a  P  value  <  0.20  in  uni-
variate  analysis  were  then  considered  in  a  logistic  regression
model  to  identify  independent  predictors  of  AF  termination
by  ablation.  A  similar  analysis  was  performed  regarding  the
l
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dt in whom persistent AF was not terminated during the procedure
bsence  of  AF  recurrence  during  the  1-year  period.  All  sta-
istical  analyses  were  performed  using  SAS  software,  version
.1  (SAS  Institute,  Cary,  NC,  USA).
esults
atient characteristics
he  mean  age  of  patients  was  59.9  ±  11  years  and  34  were
en  (85%).  The  mean  duration  of  AF  was  4.2  ±  2  years;
ll  (except  one  patient  with  a  formal  contraindication)
ere  receiving  amiodarone  at  the  time  of  the  procedure.
ll  patients  were  symptomatic  for  dyspnoea  and/or  pal-
itations.  The  mean  left  ventricular  ejection  fraction  was
ormal  (59.4  ±  9%)  despite  the  presence  of  structural  heart
isease  in  23  patients  (57%),  mainly  related  to  ischaemic
eart  disease.  Echocardiography  demonstrated  moderate-
o-severe  left  atrial  enlargement  with  a  mean  left  atrial
rea  of  26  ±  7.3  cm2 (IQR,  20  to  30).  Transmitral  ﬂow  varia-
les  in  persistent  AF  (peak  E  and  E/e’)  were  measured
82.3  ±  29.8  cm/s  and  13.1  ±  2.1,  respectively).  Sponta-
eous  echo  contrast  was  found  in  the  left  atrium  in  42%
f  patients.  The  group  of  patients  with  an  LAV  <  0.30  m/s
ad  signiﬁcantly  more  spontaneous  echo  contrast  than  the
roup  of  patients  with  a  higher  LAV  (63%  vs  11%;  P  =  0.001).
n  electrophysiology  study  found  a  mean  AF  cycle  length
n  the  left  atrial  appendage  of  around  176  ±  20  ms.  LAV  was
.30  ±  0.12  m/s  (IQR,  0.24  to  0.34)  (Fig.  1).
rocedural results
he  results  are  summarized  in  Fig.  2.  Twenty-six  of  the  40
atients  (65%)  had  acute  termination  of  AF  during  radiofre-
uency  ablation  (direct  AF  termination  to  sinus  rhythm  or
ia  atrial  tachycardia)  and  18  patients  (45%)  in  whom  sinus
hythm  was  restored  without  electrical  cardioversion.
Among  the  10  patients  with  direct  termination  to  sinus
hythm,  AF  termination  occurred  in  two  patients  (20%)  dur-
ng  pulmonary  vein  isolation  and  in  four  patients  (40%)  during
ine  ablation.  Defragmentation  of  the  left  atria  resulted
n  direct  termination  to  sinus  rhythm  in  three  patients
30%).  Defragmentation  of  the  right  atria  led  to  termination
irectly  to  sinus  rhythm  in  one  patient  (10%).
40  S.  Combes  et  al.
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Based  on  ROC  curve  analysis  of  LAV  (Fig.  3),  the  opti-
mal  cutoff  point  was  0.30  m/s,  with  a  speciﬁcity  of  72.8%
and  a sensitivity  of  77.8%  for  predicting  procedural  AF
Figure 3. Receiver operating characteristics curve showing the
prognostic value of left atrial appendage peak ﬂow velocity forigure 2. Flow chart of the study. AF: atrial ﬁbrillation; AT: atri
eak ﬂow velocity; SR: sinus rhythm.
AF  organized  into  atrial  tachycardia  in  16  patients,  eight
f  whom  converted  into  sinus  rhythm  with  further  ablation.
he  atrial  tachycardia  mechanisms  were  perimitral  (n  =  4),
avotricuspid  isthmus  dependent  (n  =  1)  and  focal  (n  =  3).
mong  the  16  patients  with  atrial  tachycardia,  two  had  AF
rganization  to  atrial  tachycardia  after  pulmonary  vein  iso-
ation,  two  after  roof  line,  three  after  mitral  isthmus  line
nd  six  after  coronary  sinus  defragmentation.  In  the  addi-
ional  three  patients,  AF  organized  into  atrial  tachycardia
uring  subsequent  complex  fractionated  atrial  electrogram
blation.
The  14  patients  (35%)  who  did  not  experience  AF
ermination  after  stepwise  ablation  underwent  electrical
ardioversion.
Mean  procedural  time  was  201  ±  43  minutes  with  a  ﬂuo-
oscopy  time  of  46  ±  19  minutes.
rediction of AF termination during catheter
blation procedure
omparison  of  baseline  characteristics  between  patients
ith  and  without  AF  termination  is  shown  in  Table  1.  Using
egression  analysis,  shorter  AF  duration  (odds  ratio  [OR]
.86,  95%  conﬁdence  interval  [CI]  1.21—19.47;  P  =  0.03),
igh  LVA  (OR  8.67,  95%  CI  2.01—37.36;  P <  0.01),  smaller
eft  atrial  area  (OR  3.81,  95%  CI  0.99—14.64;  P  =  0.05)  and
onger  AF  cycle  length  in  the  left  atrial  appendage  (OR  4.89,
5%  CI  1.25—19.19;  P  =  0.02)  were  all  signiﬁcantly  associ-
ted  with  perprocedural  AF  termination  (Table  2).  However,
t
a
o
thycardia; DCC: direct current cardioversion; LAV: left appendage
n multivariable  analysis,  only  LAV  remained  signiﬁcant  (OR
.91,  95%  CI  1.06—32.88;  P  =  0.04).he prediction of atrial ﬁbrillation (AF) termination after catheter
blation. The optimal cutoff point was 0.30 m/s, with a speciﬁcity
f 72.8% and a sensitivity of 77.8% for predicting procedural AF
ermination.
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Table  1  Characteristics  of  patients  with  and  without  atrial  ﬁbrillation  (AF)  termination  during  the  procedure.
Characteristic  No  AF  termination  (n  =  22)  AF  termination  (n  =  18)  P
Age  (years)  61.1  ±  8.6  58.7  ±  13.5  0.71
Men  19  (86)  14  (77)  0.47
Duration  of  AF  (months) 56.3  ±  39.0 40.3  ±  26.7 0.11
LAV  (m/s) 0.24  ±  0.09 0.37  ±  0.13 0.0014
LVEF  (%) 57.2  ±  9.2 63.3  ±  7.9 0.04
Left  atrial  area  (cm2)  28.6  ±  6.1  22.7  ±  7.5  0.02
AF  cycle  length  (ms)  170.0  ±  20.3  179.0  ±  15.1  0.10
Peak  E  (cm/s)  85.4  ±  30.1  79.8  ±  29.1  0.12
E/e’  index  13.2  ±  2.3  12.8  ±  2.1  0.16
Data are mean ± standard deviation or number (%) of patients. AF: atrial ﬁbrillation; LAV: left atrial appendage peak ﬂow velocity;
LVEF: left ventricular ejection fraction.
Table  2  Predictive  analysis  of  atrial  ﬁbrillation  (AF)  termination  by  catheter  ablation.
Univariate  analysis  OR  (95%  CI)  P  Multivariable  analysis  OR  (95%  CI)  P
Age  ≥  65  years  1.28  (0.36—4.60)  0.70
Duration  of  AF  <  25  months  4.86  (1.21—19.47)  0.03  2.40  (0.37—15.39)  0.35
LAV  >  0.30  m/s  8.67  (2.01—37.36)  0.004  5.91  (1.06—32.88)  0.04
LVEF  >  60%  3.47  (0.90—13.31)  0.07
Left  atrial  area  <  25  cm2 3.81  (0.99—14.64)  0.05  3.18  (0.55—18.42)  0.19
AF  cycle  length  >  175  ms  4.89  (1.25—19.19)  0.02  4.43  (0.83—23.56)  0.08
AF: atrial ﬁbrillation; CI: conﬁdence interval: LAV: left atrial appendage peak ﬂow velocity; LVEF: left ventricular ejection fraction; OR:
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termination;  the  area  under  the  curve  was  estimated  to
be  0.81  (95%  CI  0.68  −  0.95;  P  <  0.001).  The  cutoff  point  of
0.30  m/s  corresponded  to  positive  and  negative  predictive
values  of  70%  and  80%,  respectively.  Moreover,  by  combining
both  LAV  ≥  0.30  m/s  and  left  atrial  area  <  25  cm2,  the  speci-
ﬁcity  reached  100%  for  predicting  procedural  AF  termination
(sensitivity,  50%;  positive  predictive  value,  100%;  negative
predictive  value,  71%).
Prediction of no  atrial arrhythmia recurrences
during the 1-year follow-up
The  1-year  follow-up  was  completed  in  all  patients.  Over-
all,  sinus  rhythm  was  maintained  in  18  patients  (45%).
Eight  patients  from  the  no  termination  AF  group  were
in  persistent  sinus  rhythm  during  the  follow-up  at  1  year.
AF  cycle  length  was  longer  in  patients  without  AF  recur-
rence  (167.2  ±  16  ms  vs  183.9  ±  17  ms;  P  =  0.01).  There  were
no  signiﬁcant  differences  regarding  left  atrial  area,  AF
duration,  left  ventricular  ejection  fraction  and  demo-
graphics  between  the  two  groups.  In  contrast,  LAV  was
higher  in  the  recurrence-free  group  during  the  follow-up
(0.25  ±  0.10  m/s  vs  0.36  ±  0.13  m/s;  P  =  0.006);  AF  recur-
rence  rates  at  1  year  according  to  LAV  (cutoff  value  ﬁxed
at  0.30  m/s)  differed  signiﬁcantly  (75%  vs  35%;  P  =  0.01)
(Fig.  2).  Logistic  regression  analysis  is  presented  in  Table  3.
In  multivariable  analysis,  only  LAV  remained  signiﬁcant  for
predicting  AF  recurrence  (OR  4.33,  95%  CI  1.05—17.81;  P  =
0.04).
a
n
a
Piscussion
n  this  pilot  study,  carried  out  in  the  setting  of  long-standing
F,  LAV  measurement  has  been  found  to  be  of  particular
nterest  in  predicting  procedural  success  of  catheter  abla-
ion  as  well  as  arrhythmia  recurrence  rate  at  mid  term.
Catheter  ablation  of  AF  has  been  used  for  about  10  years.
or  long-standing  persistent  AF,  ablation  strategies  vary  con-
iderably  between  centres  and  success  rates  range  between
8%  and  >  62%  after  one  procedure  [13—15]. To  improve
lobal  results,  optimization  of  patient  selection  must  be
arried  out;  identiﬁcation  of  predictors  of  favourable  out-
omes,  using  minimally  invasive  measurements,  is  crucial  in
his  setting.
The  concept  of  a  link  between  LAV  and  clinical  outcome
s  based  on  a  solid  rationale.  Important  literature  empha-
ized  the  central  role  of  atrial  tissue  mass  and  histology
n  the  pathogenesis  of  AF  [16]. In  persistent  AF,  the  left
trium  undergoes  remodelling  processes  that  are  believed
o  be  pathophysiological  factors  for  persistence  of  AF  [17].
n  addition  to  structural  remodelling  mainly  focused  on  the
ntercellular  matrix,  AF  causes  atrial  electrophysiological
emodelling,  changes  in  connexin  density  and  distribution,
ellular  structural  remodelling,  myolysis  and  glycogen  accu-
ulation,  according  to  the  well-known  concept  summarized
s  ‘AF  begets  AF’  [18—20]. LA  function  is  difﬁcult  to  assess
on-invasively  and  some  studies  have  evaluated  left  atrial
ppendage  function—particularly  LAV—as  a  surrogate  [21].
eak  left  atrial  appendage  emptying  velocity  appears  to  be
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Table  3  Predictive  analysis  of  the  absence  of  atrial  arrhythmia  recurrence  at  1-year  follow-up.
Characteristic  Univariate  analysis  OR  (95%  CI)  P  Multivariable  analysis  OR  (95%  CI)  P
Age  ≥  65  years 0.84  (0.23—3.02)  0.79
Duration  of  AF  <  25  months  1.97  (0.51—7.05)  0.33
LAV  >  0.30  m/s  5.14  (1.30—20.36)  0.02  4.33  (1.05—17.81)  0.04
LVEF  >  60%  2.20  (0.60—8.08)  0.26
Left  atrial  area  <  25  cm2 1.56  (0.43—5.64)  0.50
AF  cycle  length  >  175  ms 3.06 (0.82—11.44) 0.09  2.25 (0.55—9.28)  0.26
AF: atrial ﬁbrillation; CI: conﬁdence interval: LAV: left atrial appendage peak ﬂow velocity; LVEF: left ventricular ejection fraction; OR:
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 complex  variable  that  depends  on  left  atrial  function  [22].
eft  atrium  and  left  atrial  appendage  are  two  distinct  histo-
ogical  structures.  Because  of  its  increased  distensibility,  the
eft  atrial  appendage  may  increase  its  haemodynamic  func-
ion  by  modulating  left  atrial  pressure-volume  relations  in
tates  of  increased  left  atrial  pressure  and  volume  overload
r  atrial  ﬁbrosis  [23]. This  replacement  of  atrial  contractile
issue  by  ﬁbrosis  supports  our  hypothesis  that  a  lower  LAV
ould  be  associated  with  a  lower  rate  of  catheter  ablation
rocedure  success  and  a  higher  rate  of  recurrence  at  mid
erm.
Only  a  few  previous  studies  have  investigated  the
mportance  of  LAV  measured  by  transoesophageal  echocar-
iography  before  AF  cardioversion.  These  studies  showed
hat  LAV  is  one  of  the  strongest  predictors  of  atrial
ysfunction  and  sinus  rhythm  persistence  after  AF  elec-
rical  cardioversion  [24,25].  In  a  prospective  multicentre
tudy  of  193  patients,  Antonielli  et  al.  [26]  showed  that
AV  >  0.40  m/s  could  independently  predict  sinus  rhythm
ersistence  at  1  year  after  successful  electrical  cardiover-
ion,  with  a  negative  predictive  value  of  66%  and  a  positive
redictive  value  of  73%.  To  our  knowledge,  our  pilot  study
s  the  ﬁrst  demonstrating  that  high  LAV  is  a  predictor  of
mmediate  and  mid-term  success  after  AF  catheter  ablation.
A  number  of  series  of  patients  treated  for  long-standing
ersistent  AF  demonstrated  that  perprocedural  termina-
ion  of  persistent  AF  is  associated  with  a  better  clinical
utcome  [13,27,28]. As  in  our  study,  AF  termination  and
ong-term  persistence  of  sinus  rhythm  after  AF  ablation  were
trongly  linked,  with  very  similar  predicting  factors  [29].
n  a  study  of  catheter  ablation  for  persistent  AF,  Matsuo
t  al.  demonstrated  that  long  AF  cycle  length  on  surface
lectrocardiograms  is  independently  associated  with  sinus
hythm  persistence  [9].  Left  atrial  dimension,  a  well-known
arker  of  left  atrial  disease,  has  been  found  to  be  inferior
o  AF  cycle  length  as  a  predictor  of  the  occurrence  of  subse-
uent  atrial  tachycardia  [30,31].  In  a  group  of  148  patients,
erruezo  et  al.  demonstrated  that  the  anterior-posterior  left
trial  diameter  was  an  independent  predictor  of  AF  recur-
ence  after  AF  catheter  ablation  [32]. These  ﬁndings  were
onﬁrmed  by  Shin  et  al.  who  found  left  atrial  volume  to  be
 signiﬁcant  predictor  of  AF  recurrence  after  catheter  abla-
ion  in  a  group  of  68  patients  [33]. In  our  study,  left  atrial
imension  was  signiﬁcantly  associated  with  perprocedural
F  termination  in  univariate  analysis.  After  adjustment,  we
oted  only  a  slight  trend  for  predicting  arrhythmia  recur-
ence,  which  remained  non-signiﬁcant  mainly  due  to  the
D
T
cimited  number  of  patients  enrolled  in  this  pilot  study.  Signif-
cantly  dilated  atria  are  generally  thought  to  be  associated
ith  a  high  degree  of  atrial  remodelling,  which  limits  the
fﬁcacy  of  catheter  ablation.  Recent  studies  [34]  demon-
trated  that  the  degree  of  ﬁbrosis  detected  by  sophisticated
maging  systems  was  highly  associated  with  procedural  suc-
ess  and  outcome,  emphasizing  our  hypothesis  that  a  low
AV  is  a predictor  of  an  unfavourable  outcome;  a  recent
tudy  by  Mahnkopf  et  al.  demonstrated  that  increased
elayed  enhancement  within  the  left  atrial  wall  on  mag-
etic  resonance  imaging  is  strongly  associated  with  AF
ecurrence,  regardless  of  the  type  of  AF  and  the  patient’s
omorbidities  [35]. Additionally,  in  a  cohort  of  81  patients,
akes  et  al.  reported  that  late  gadolinium  enhancement  of
he  left  atrium  on  magnetic  resonance  imaging  was  cor-
elated  with  the  extent  of  left  atrial  ﬁbrosis  measured  by
 voltage  map  and  with  the  odds  of  procedural  success
10].
tudy limitations
lthough  our  study  is  the  ﬁrst  to  prospectively  evalu-
te  the  value  of  LA  appendage  velocity  in  the  setting  of
ong-standing  persistent  AF,  we  acknowledge  some  limita-
ions.  First,  our  sample  size  was  small.  However,  in  spite
f  this  relatively  low  number  of  patients,  the  predictive
alue  of  LAV  was  highly  signiﬁcant.  Second,  as  is  usual
n  AF  studies,  ECG  and  periodic  Holter  monitoring  may
ave  led  to  some  degree  of  underestimation  of  recurrence
ates.
onclusions
n  conclusion,  in  the  setting  of  long-standing  persistent
F,  high  LAV  appears  to  be  particularly  efﬁcient  in  accu-
ately  predicting  AF  termination  by  radiofrequency  catheter
blation  as  well  as  persistence  of  sinus  rhythm  during
ollow-up.  Our  results  should  encourage  further  stud-
es  to  conﬁrm  the  value  of  considering  LAV  in  routine
ractice.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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